Last10K.com

Acm Research, Inc. (ACMR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

Acm Research, Inc.

CIK: 1680062 Ticker: ACMR

 
Exhibit 99.01

ACM Research Reports First Quarter 2022 Results
 
FREMONT, California, May 6, 2022 (Globe Newswire) – ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its first fiscal quarter ended March 31, 2022.
 
“As we announced on April 7 and April 27, our results for the first quarter of 2022 were significantly impacted by the COVID-19 related restrictions in Shanghai, which limited employee access and logistics activities of our facilities in Pudong,” said Dr. David Wang, ACM’s President and Chief Executive Officer. “The lockdown impacted ACM’s ability to ship finished products to customers and the pace of our production, even with some employees continuing to work in our factories. Although restrictions are still impacting operations early in the second quarter, demand for ACM’s tools remains strong. As a result of ACM having been added to the Shanghai government’s “White List” of essential businesses, we have begun to increase the level of our operational activities.”
 
“We have partly offset the effects of the lockdown, as our Shanghai R&D and management teams have been working from home and our operations in other regions, including our South Korea R&D and production facilities, have remained open,” Dr. Wang continued. “With a diversified supply chain, we are hopeful that the lifting of logistics bottlenecks to and from our Shanghai facilities will allow for a timely return to normal production levels.”
 
Dr. Wang concluded, “Looking beyond this unprecedented lockdown, we are planning for solid growth in 2022 from our core cleaning products, the ongoing product cycle for our electrochemical plating tools, and the initial ramp of our furnace products. We are committed to gaining additional share of the $8 billion market addressed by our current products, and we remain on track to double our addressable market opportunity with the upcoming introduction of two new product categories. We will continue to invest in new product development and additional production capacity and to support ongoing tool evaluations with major semiconductor manufacturers.”
 
   
Three Months Ended March 31,
 
   
GAAP
   
Non-GAAP(1)
 
   
2022
   
2021
   
2022
   
2021
 
   
(dollars in thousands, except EPS)
 
Revenue
 
$
42,186
   
$
43,732
   
$
42,186
   
$
43,732
 
Gross margin
   
46.7
%
   
41.3
%
   
46.9
%
   
41.4
%
Income (loss) from operations
 
$
(9,306
)
 
$
3,450
   
$
(7,932
)
 
$
4,660
 
Net income (loss) attributable to ACM Research, Inc.
 
$
(5,786
)
 
$
5,470
   
$
(554
)
 
$
7,727
 
Basic EPS (2)
 
$
(0.10
)
 
$
0.10
   
$
(0.01
)
 
$
0.14
 
Diluted EPS (2)(3)
 
$
(0.09
)
 
$
0.08
   
$
(0.01
)
 
$
0.12
 
(1)
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted EPS, also exclude unrealized loss on trading securities.
 
(2)
Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.
 
(3)
Diluted EPS includes an impact of $86,000 in the first quarter of 2022 from dilutive shares of ACM Research (Shanghai), Inc.
 
Outlook
 
The Company is maintaining its revenue guidance range of $365 million to $405 million for fiscal year 2022. This expectation assumes, among other factors, stability with respect to the global COVID-19 pandemic and US-China trade policy, and a timely return to scale of ACM’s production and shipping operations in Shanghai. The range of ACM’s 2022 outlook reflects, among other things, various spending scenarios for the production ramps of key customers, the absence of unexpected disruptions in ACM’s supply chain, and the timing of acceptances for first tools under evaluation in the field.


Operating Highlights and Recent Announcements
 
Shipments. Total shipments in the first quarter of 2022 were $67 million, versus $74 million in the first quarter of 2021. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters. The lockdown resulted in ACM’s having to defer shipment of 13 tools that had been scheduled to ship during the first quarter of 2022.
 
Mass Production for 18 Chamber, 300mm Ultra C VI Single-Wafer Cleaning Tool. In April 2022, ACM announced that its 18 chamber, 300mm Ultra C VI single wafer cleaning tool had been qualified by a customer and successfully moved to mass production in ACM’s factory. First introduced to the market in the second quarter of 2020, the tool has also been qualified for mass production by a mainstream memory chip manufacturer in China.
 
Completion of 3-for-1 Stock Split Effected in Form of a Stock Dividend. In March 2022, ACM completed a 3-for-1 stock split of ACM’s Class A common stock and Class B common stock in the form of a stock dividend.
 
Financial Summary
 
Unless otherwise noted, the following figures refer to the first quarter of 2022 and comparisons are with the first quarter of 2021.
 
Revenue was $42.2 million, down 3.5%, reflecting lower revenue from single wafer wet cleaning tools, advanced packaging and other back-end processing equipment as the result ofCOVID-19 restrictions in Shanghai. Revenue from both repeat shipments and customer acceptances was negatively impacted by the Shanghai lockdown.
 
Gross margin was 46.7%, up from 41.3%. Non-GAAP gross margin, which excludes stock-based compensation, was 46.9%, up from 41.4%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume and product mix.
 
Operating expenses were $29.0 million, an increase of 98.6%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $27.7 million, up 106.1%.  Non-GAAP operating expenses as a percent of revenue increased to 65.7% from 30.8%. The increase in operating expenses was due primarily to higher research and development spending, including increased spending on new products and costs incurred for development tools.
 
Operating loss was $9.3 million, up from $3.5 million.  Non-GAAP operating loss, which excludes the effect of stock-based compensation, was $7.9 million, up from $4.7 million.
 
Unrealized loss on trading securities was $3.9 million. The loss reflects the change in market value of the indirect investment by ACM Research (Shanghai), Inc. in STAR Market IPO shares of Semiconductor Manufacturing International Corporation (SMIC). The value is marked-to-market quarterly and is excluded from non-GAAP results.
 
Income tax benefit was $4.0 million, compared to $2.8 million. The income tax benefit for the period ending March 31, 2022 primarily resulted from the tax effect of the operating loss together with a significant increase in ACM’s effective income tax rate. As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986 that became effective on January 1, 2022, the effective tax rate for 2022 has increased, primarily due to a new requirement to capitalize and amortize previously deductible research and experimental expenses. The income tax benefit for the period ended March 31, 2021 resulted from discrete tax benefits associated with stock-based compensation, and a lower effective tax rate prior to the change in Section 174.
 
Net loss attributable to ACM Research, Inc. was $5.8 million, compared to net income of $5.5 million.  Non-GAAP net loss attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.6 million, as compared to non-GAAP net income of $7.7 million.
 
-2-


Net loss per diluted share attributable to ACM Research, Inc. was $0.09, compared to net income per diluted share of $0.08.  Non-GAAP net loss per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.01, compared to non-GAAP net income per diluted share of $0.12.
 
Cash and cash equivalents were $380.3 million at March 31, 2022, versus $563.1 million at December 31, 2021.  Cash and cash equivalents plus short-term and long-term time deposits were $533.1 million at March 31, 2022, versus $563.1 million at December 31, 2021.
 
Conference Call Details
 
A conference call to discuss results will be held on Friday, May 6, 2022, at 8:00 a.m. Eastern Time (8:00 p.m. China Time). Dial-in details for the call are as follows. Please reference conference ID 4392303.

 
Phone Number
Toll-Free Number
United States
+1 (661) 567-1217
+1 (833) 562-0137
Hong Kong
+852 5819 4851
+852 8009 66253
Mainland China
+86 8008700169
+86 4006828609
 

A recording of the webcast will be available on the investor page of the ACM website at www.acmrcsh.com for one week following the call.
 
Use of Non-GAAP Financial Measures
 
ACM presents non-GAAP gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS exclude non-cash change in fair value of financial assets and liabilities and unrealized gain on trading securities, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of Non-GAAP to GAAP Financial Measures.”
 
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
 
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
 
-3-

Forward-Looking Statements
 
Certain statements contained in the second, third and fourth paragraphs of this press release and under the heading “Outlook” above are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the intent, belief and current expectations with respect to: the extent and effect of the Shanghai COVID-19 lockdown; the demand for ACM’s tools, including specifically in fiscal year 2022; the expansion in 2022 of ACM’s product offering, production capacity and base of major customers; and the timing and ability of ACM to secure orders from new customers.  Those statement are expectations only, reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the following, any of which could be exacerbated even further by the continuing COVID-19 outbreak in China and globally: anticipated customer orders or identified market opportunities may not grow or develop as anticipated; customer orders already received may be postponed or canceled; ACM may be unable to obtain the qualification and acceptance of its delivered tools when anticipated or at all, which would delay or preclude ACM’s recognition of revenue from the sale of those tools; suppliers may not be able to meet ACM’s demands on a timely basis; ACM’s technologies and tools may not gain market acceptance; ACM may be unable to compete effectively by, among other things, enhancing its existing tools, adding additional production capacity and engaging additional major customers; volatile global economic, market, industry and other conditions could result in sharply lower demand for products containing semiconductors and for the Company's products and in disruption of capital and credit markets; trade regulations, currency fluctuations, political instability and war may materially adversely affect ACM due to its substantial non-U.S. customer and supplier base and its substantial non-U.S. manufacturing operations. ACM cannot guarantee any future results, levels of activity, performance or achievements.  ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations  regarding these forward-looking statements or the occurrence of unanticipated events.
 
About ACM Research, Inc.
 
ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The Company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.
 
© ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.
 
For investor and media inquiries, please contact:
 
In the United States:
The Blueshirt Group
 
 
Yujia Zhai
 
 
+1 (860) 214-0809
 
 
yujia@blueshirtgroup.com
 
     
In China:
The Blueshirt Group Asia
 
 
Gary Dvorchak, CFA
 
 
+86 (138) 1079-1480
 
 
gary@blueshirtgroup.com
 

-4-

ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets

   
March 31, 2022
   
December 31, 2021
 
   
(Unaudited)
 
   
(In thousands, except share
and per share data)
 
Assets
           
Current assets:
           
Cash and cash equivalents
 
$
380,311
   
$
563,067
 
Short-term time deposits
   
74,025
     
-
 
Trading securities
   
25,772
     
29,498
 
Accounts receivable, less allowance for doubtful accounts of $0 as of March 31, 2022 and December 31, 2021
   
106,351
     
105,553
 
Income tax recoverable
   
1,607
     
1,082
 
Other receivables
   
23,602
     
18,979
 
Inventories
   
271,538
     
218,116
 
Prepaid expenses
   
21,771
     
16,639
 
Total current assets
   
904,977
     
952,934
 
Property, plant and equipment, net
   
57,680
     
14,042
 
Land use right, net
   
9,661
     
9,667
 
Operating lease right-of-use assets, net
   
4,028
     
4,182
 
Intangible assets, net
   
748
     
477
 
Long-term time deposits
   
78,750
     
-
 
Deferred tax assets
   
15,303
     
13,166
 
Long-term investments
   
12,666
     
12,694
 
Other long-term assets
   
3,559
     
45,017
 
Total assets
   
1,087,372
     
1,052,179
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
Short-term borrowings
   
9,600
     
9,591
 
Current portion of long-term borrowings
   
2,441
     
2,410
 
 Accounts payable
   
108,494
     
101,350
 
Advances from customers
   
82,036
     
52,824
 
Deferred revenue
   
2,699
     
3,180
 
Income taxes payable
   
(1,744
)
   
254
 
FIN-48 payable
   
2,292
     
2,282
 
Other payables and accrued expenses
   
36,555
     
31,735
 
Current portion of operating lease liability
   
2,076
     
2,313
 
Total current liabilities
   
244,449
     
205,939
 
 Long-term borrowings
   
22,344
     
22,957
 
Long-term operating lease liability
   
1,952
     
1,869
 
Deferred tax liability
   
1,308
     
1,302
 
Other long-term liabilities
   
8,545
     
8,447
 
Total liabilities
   
278,598
     
240,514
 
Commitments and contingencies
               
Stockholders’ equity:
               
Common stock (1) – Class A, par value $0.0001: 150,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 54,035,280 shares issued and outstanding as of March 31, 2022 and 53,608,929 shares issued and outstanding as of December 31, 2021
   
5
     
5
 
Common stock (1) – Class B, par value $0.0001:  5,307,816 shares authorized as of March 31, 2022 and December 31, 2021; 5,086,812 shares issued and outstanding as of March 31, 2022 and 5,087,814 shares issued and outstanding as of December 31, 2021
   
1
     
1
 
Additional paid in capital
   
597,143
     
595,045
 
Accumulated surplus
   
66,258
     
72,044
 
Accumulated other comprehensive income
   
10,979
     
9,109
 
Total ACM Research, Inc. stockholders’ equity
   
674,386
     
676,204
 
Non-controlling interests
   
134,388
     
135,461
 
Total stockholders’ equity
   
808,774
     
811,665
 
Total liabilities and stockholders’ equity
 
$
1,087,372
   
$
1,052,179
 
 
 (1) Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.

-5-

ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Income
 
   
Three Months Ended March 31,
 
   
2022
   
2021
 
   
(Unaudited)
 
   
( In thousands, except share and per share data)
 
Revenue
 
$
42,186
   
$
43,732
 
Cost of revenue
   
22,500
     
25,687
 
Gross profit
   
19,686
     
18,045
 
Operating expenses:
               
Sales and marketing
   
6,697
     
5,308
 
Research and development
   
17,346
     
5,504
 
General and administrative
   
4,949
     
3,783
 
Total operating expenses, net
   
28,992
     
14,595
 
Income (loss) from operations
   
(9,306
)
   
3,450
 
Interest income
   
1,805
     
49
 
Interest expense
   
(261
)
   
(189
)
Unrealized loss on trading securities
   
(3,858
)
   
(1,047
)
Other income, net
   
237
     
469
 
Equity income (loss) in net income (loss) of affiliates
   
(71
)
   
320
 
Income (loss) before income taxes
   
(11,454
)
   
3,052
 
Income tax benefit
   
4,011
     
2,770
 
Net income (loss)
   
(7,443
)
   
5,822
 
Less: Net income (loss) attributable to non-controlling interests
   
(1,657
)
   
352
 
Net income (loss) attributable to ACM Research, Inc.
 
$
(5,786
)
 
$
5,470
 
Comprehensive income:
               
Net income (loss)
   
(7,443
)
   
5,822
 
Foreign currency translation adjustment
   
2,454
     
(1,332
)
Comprehensive Income (loss)
   
(4,989
)
   
4,490
 
Less: Comprehensive income (loss) attributable to non-controlling interests
   
(1,073
)
   
(83
)
Comprehensive income (loss) attributable to ACM Research, Inc.
 
$
(3,916
)
 
$
4,573
 
 
               
Net income (loss) attributable to ACM Research, Inc. per common share (1):
               
Basic
 
$
(0.10
)
 
$
0.10
 
Diluted
 
$
(0.09
)
 
$
0.08
 
 
               
Weighted average common shares outstanding used in computing per share amounts (1):
               
Basic
   
58,827,390
     
56,360,610
 
Diluted
   
65,950,922
     
65,604,840
 

(1) Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.

-6-

ACM RESEARCH, INC.
Total Revenue by Product Category, by Equipment Type and by Region
 
`
 
Three Months Ended March 31,
 
   
2022
   
2021
 
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
 
$
26,033
   
$
32,413
 
ECP (front-end and packaging), furnace and other technologies
   
12,248
     
5,550
 
Advanced packaging (excluding ECP), services & spares
   
3,905
     
5,769
 
Total Revenue By Product Category
 
$
42,186
   
$
43,732
 
                 
Wet cleaning and other front-end processing tools
 
$
31,702
   
$
31,900
 
Advanced packaging, other processing tools, services and spares
   
10,484
     
11,832
 
Total Revenue Front-end and Back-End
 
$
42,186
   
$
43,732
 

   
Three Months Ended March 31,
 
     
2022
     
2021
 
Mainland China
 
$
42,130
   
$
43,696
 
Other Regions
   
56
     
36
 
 
 
$
42,186
   
$
43,732
 
 
-7-

ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
 
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (SBC) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude non-cash change in fair value of financial liabilities and unrealized gain on trading securities. The following table reconciles gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:

   
Three Months Ended March 31,
 
   
2022
   
2021
 
    
Actual
(GAAP)
    
SBC
   
Other non-operating adjustments
    
Adjusted
(Non-GAAP)
     
Actual
(GAAP)
    
SBC
   
Other non-operating adjustments
    
Adjusted
(Non-GAAP)
 
 
   
(In thousands)
 
 
                                               
Revenue
 
$
42,186
   
$
-
   
$
-
   
$
42,186
   
$
43,732
   
$
-
   
$
-
   
$
43,732
 
Cost of revenue
   
(22,500
)
   
(113
)
   
-
     
(22,387
)
   
(25,687
)
   
(71
)
   
-
     
(25,616
)
Gross profit
   
19,686
     
(113
)
   
-
     
19,799
     
18,045
     
(71
)
   
-
     
18,116
 
Operating expenses:
                                                               
Sales and marketing
   
(6,697
)
   
(354
)
   
-
     
(6,343
)
   
(5,308
)
   
(505
)
   
-
     
(4,803
)
Research and development
   
(17,346
)
   
(411
)
   
-
     
(16,935
)
   
(5,504
)
   
(229
)
   
-
     
(5,275
)
General and administrative
   
(4,949
)
   
(496
)
   
-
     
(4,453
)
   
(3,783
)
   
(405
)
   
-
     
(3,378
)
Income (loss) from operations
 
$
(9,306
)
 
$
(1,374
)
 
$
-
   
$
(7,932
)
 
$
3,450
   
$
(1,210
)
 
$
-
   
$
4,660
 
Unrealized loss on trading securities
   
(3,858
)
   
-
     
(3,858
)
   
-
     
(1,047
)
   
-
     
(1,047
)
   
-
 
Net income (loss) attributable to ACM Research, Inc.
 
$
(5,786
)
 
$
(1,374
)
 
$
(3,858
)
 
$
(554
)
 
$
5,470
   
$
(1,210
)
 
$
(1,047
)
 
$
7,727
 
Basic EPS(1)
 
$
(0.10
)
                 
$
(0.01
)
 
$
0.10
                   
$
0.14
 
Diluted EPS(1)
 
$
(0.09
)
                 
$
(0.01
)
 
$
0.08
                   
$
0.12
 

(1) Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.

-8-


The following information was filed by Acm Research, Inc. (ACMR) on Friday, May 6, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Acm Research, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acm Research, Inc..

Continue

Assess how Acm Research, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acm Research, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Cash Flow
Earnings
Expense
Income
Product
Geography
Other
Inside Acm Research, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Changes In Stockholders' Equity
Condensed Consolidated Statements Of Changes In Stockholders' Equity (Parenthetical)
Condensed Consolidated Statements Of Operations And Comprehensive Income
Condensed Consolidated Statements Of Operations And Comprehensive Income (Parenthetical)
Accounts Receivable
Accounts Receivable (Details)
Accounts Receivable (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Common Stock
Common Stock (Details)
Description Of Business
Description Of Business (Details)
Description Of Business (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Inventories
Inventories (Details)
Inventories (Tables)
Land Use Right, Net
Land Use Right, Net (Details)
Land Use Right, Net (Tables)
Leases
Leases (Details)
Leases (Tables)
Long-Term Borrowings
Long-Term Borrowings (Details)
Long-Term Borrowings (Tables)
Long-Term Investment
Long-Term Investment (Details)
Long-Term Investment (Tables)
Other Long-Term Assets
Other Long-Term Assets (Details)
Other Long-Term Assets (Tables)
Other Long-Term Liabilities
Other Long-Term Liabilities (Details)
Other Long-Term Liabilities (Tables)
Other Payable And Accrued Expenses
Other Payable And Accrued Expenses (Details)
Other Payable And Accrued Expenses (Tables)
Property, Plant And Equipment, Net
Property, Plant And Equipment, Net (Details)
Property, Plant And Equipment, Net (Tables)
Related Party Balances And Transactions
Related Party Balances And Transactions (Details)
Related Party Balances And Transactions (Tables)
Revenue From Contracts With Customers
Revenue From Contracts With Customers (Details)
Revenue From Contracts With Customers (Tables)
Short-Term Borrowings
Short-Term Borrowings (Details)
Short-Term Borrowings (Tables)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation, Assumptions Used To Determine Fair Value Of Share Options Granted (Details)
Stock-Based Compensation, Share Option Activities (Details)
Stock-Based Compensation, Stock-Based Compensation Expense (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies, Basic And Diluted Net Income Per Common Share (Details)
Summary Of Significant Accounting Policies, Concentration Of Credit Risk (Details)
Trading Securities
Trading Securities (Details)
Trading Securities (Tables)

Material Contracts, Statements, Certifications & more

Acm Research, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ACMR
CIK: 1680062
Form Type: 10-Q Quarterly Report
Accession Number: 0001140361-22-018324
Submitted to the SEC: Mon May 09 2022 5:01:49 PM EST
Accepted by the SEC: Mon May 09 2022
Period: Thursday, March 31, 2022
Industry: Special Industry Machinery

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acmr/0001140361-22-018324.htm